Kinetic modeling of 68Ga-PSMA-11 and validation of simplified methods for quantification in primary prostate cancer patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2191-219X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Kinetic modeling of 68Ga-PSMA-11 and validation of simplified methods for quantification in primary prostate cancer patients ; volume:10 ; number:1 ; day:24 ; month:2 ; year:2020 ; pages:1-10 ; date:12.2020
EJNMMI Research ; 10, Heft 1 (24.2.2020), 1-10, 12.2020
- Urheber
-
Ringheim, Anna
Campos Neto, Guilherme de Carvalho
Anazodo, Udunna
Cui, Lumeng
Cunha, Marcelo Livorsi da
Vitor, Taise
Martins, Karine Minaif
Miranda, Ana Cláudia Camargo
Barboza, Marycel Figols de
Fuscaldi, Leonardo Lima
Lemos, Gustavo Caserta
Colombo Junior, José Roberto
Baroni, Ronaldo Hueb
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13550-020-0594-6
- URN
-
urn:nbn:de:101:1-2020052607200679135612
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ringheim, Anna
- Campos Neto, Guilherme de Carvalho
- Anazodo, Udunna
- Cui, Lumeng
- Cunha, Marcelo Livorsi da
- Vitor, Taise
- Martins, Karine Minaif
- Miranda, Ana Cláudia Camargo
- Barboza, Marycel Figols de
- Fuscaldi, Leonardo Lima
- Lemos, Gustavo Caserta
- Colombo Junior, José Roberto
- Baroni, Ronaldo Hueb
- SpringerLink (Online service)
Ähnliche Objekte (12)
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
68Ga-PSMA and 68Ga-FAPI radioligands in the diagnosis of tumors
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target
Comparison of tracer kinetic models for 68Ga-PSMA-11 PET in intermediate-risk primary prostate cancer patients
68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma
68Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients
[68Ga]PSMA-PET/CT-imaging bij de diagnostiek van prostaatkanker
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
68Ga-PSMA als Radiopharmakon für die Prostatakarzinom-Bildgebung : Vergleichende Untersuchung zur Bindung von 68Ga-PSMA durch LNCaP- und PC-3 Zellen in-vitro
Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI
Antihormone treatment differentially regulates PSA secretion, PSMA expression and 68Ga–PSMA uptake in LNCaP cells
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
68Ga-PSMA and 68Ga-FAPI radioligands in the diagnosis of tumors
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target
Comparison of tracer kinetic models for 68Ga-PSMA-11 PET in intermediate-risk primary prostate cancer patients
68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma
68Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients
[68Ga]PSMA-PET/CT-imaging bij de diagnostiek van prostaatkanker
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
68Ga-PSMA als Radiopharmakon für die Prostatakarzinom-Bildgebung : Vergleichende Untersuchung zur Bindung von 68Ga-PSMA durch LNCaP- und PC-3 Zellen in-vitro
Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI
Antihormone treatment differentially regulates PSA secretion, PSMA expression and 68Ga–PSMA uptake in LNCaP cells
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
68Ga-PSMA and 68Ga-FAPI radioligands in the diagnosis of tumors
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target
Comparison of tracer kinetic models for 68Ga-PSMA-11 PET in intermediate-risk primary prostate cancer patients
68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma
68Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients
[68Ga]PSMA-PET/CT-imaging bij de diagnostiek van prostaatkanker
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
68Ga-PSMA als Radiopharmakon für die Prostatakarzinom-Bildgebung : Vergleichende Untersuchung zur Bindung von 68Ga-PSMA durch LNCaP- und PC-3 Zellen in-vitro
Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI